Sinclair Pharma Plc (SPH)-Financial and Strategic SWOT Analysis Review

Sinclair Pharma Plc (SPH)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH80664FSA
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Sinclair Pharma Plc (SPH)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is a dermatology pharmaceutical company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatology products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It also offers dermal fillers for folds and lines. Its major areas of focus include aesthetics, wound care, and skin care. Some of Sinclair's major brands include Silhouette Soft; Ellanse; Perfectha and Sculptra. The company has a presence in various countries through a network of subsidiaries. It has direct sales and marketing presence in five major European countries. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc Key Recent Developments

Jul 18, 2016: Trading update and notification of board changes 17.2m revenue in 1H calendar 2016

Mar 30, 2016: Sinclair Pharma Announces Interm Results

Aug 05, 2015: Sinclair IS Pharma: Trading Update

Feb 17, 2015: Sinclair IS Pharma Announces Its Unaudited Half Year Results For The Six Months Ended 31 December 2014

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Sinclair Pharma Plc-Key Facts 6

Sinclair Pharma Plc-Key Employees 7

Sinclair Pharma Plc-Key Employee Biographies 8

Sinclair Pharma Plc-Major Products and Services 9

Sinclair Pharma Plc-Pharmaceutical Pipeline Products Data 10

Sinclair Pharma Plc, Pipeline Products by Therapy Area 10

Sinclair Pharma Plc, Pipeline Products by Development Phase 11

Sinclair Pharma Plc-History 13

Sinclair Pharma Plc-Company Statement 16

Sinclair Pharma Plc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 20

Sinclair Pharma Plc-Business Description 20

Sinclair Pharma Plc-SWOT Analysis 21

SWOT Analysis-Overview 21

Sinclair Pharma Plc-Strengths 21

Strength-Specialized Portfolio of Aesthetic Products 21

Strength-Aesthetic Brands Drive Growth 21

Strength-Strong Sales and Distributor Network 21

Sinclair Pharma Plc-Weaknesses 22

Weakness-Decline in Non-Aesthetics Business 22

Sinclair Pharma Plc-Opportunities 23

Opportunity-Orphan Drug Designation 23

Opportunity-Business Initiatives 23

Opportunity-Growing Market for Facial Aesthetics 23

Sinclair Pharma Plc-Threats 24

Threat-Competitive Pressures 24

Threat-Increasing Counterfeit Products 24

Threat-Dependence on Third Parties 24

Sinclair Pharma Plc-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

Sinclair Pharma Plc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Jul 18, 2016: Trading update and notification of board changes 17.2m revenue in 1H calendar 2016 34

Mar 30, 2016: Sinclair Pharma Announces Interm Results 36

Aug 05, 2015: Sinclair IS Pharma: Trading Update 37

Feb 17, 2015: Sinclair IS Pharma Announces Its Unaudited Half Year Results For The Six Months Ended 31 December 2014 39

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Sinclair Pharma Plc, Pipeline Products by Therapy Area 10

Sinclair Pharma Plc, Pipeline Products by Development Phase 11

Sinclair Pharma Plc, Performance Chart (2011-2015) 28

Sinclair Pharma Plc, Ratio Charts 30

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 32

List of Tables

Sinclair Pharma Plc, Key Facts 6

Sinclair Pharma Plc, Key Employees 7

Sinclair Pharma Plc, Key Employee Biographies 8

Sinclair Pharma Plc, Major Products and Services 9

Sinclair Pharma Plc, Number of Pipeline Products by Therapy Area 10

Sinclair Pharma Plc, Number of Pipeline Products by Development Stage 11

Sinclair Pharma Plc, Pipeline Products By Therapy Area and Development Phase 12

Sinclair Pharma Plc, History 13

Sinclair Pharma Plc, Subsidiaries 18

Sinclair Pharma Plc, Key Competitors 25

Sinclair Pharma Plc, Ratios based on current share price 26

Sinclair Pharma Plc, Annual Ratios 27

Sinclair Pharma Plc, Interim Ratios 29

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

Sinclair Pharma Plc, Recent Deals Summary 33

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sinclair Pharma Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 300 INR 19305
Site License
USD 600 INR 38610
Corporate User License
USD 900 INR 57915

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com